Currently available methods for detection of tumors in vivo such as computed tomography and magnetic resonance imaging are not specific for tumors. Here we describe a new approach for visualizing tumors whose fluorescence can be detected using telomerase-specific replication-competent adenovirus expressing green fluorescent protein (GFP) (OBP-401). OBP-401 contains the replication cassette, in which the human telomerase reverse transcriptase (hTERT) promoter drives expression of E1 genes, and the GFP gene for monitoring viral replication. When OBP-401 was intratumorally injected into HT29 tumors orthotopically implanted into the rectum in BALB/c nu/nu mice, para-aortic lymph node metastasis could be visualized at laparotomy under a three-chip color cooled charged-coupled device camera. Our results indicate that OBP-401 causes viral spread into the regional lymphatic area and selectively replicates in neoplastic lesions, resulting in GFP expression in metastatic lymph nodes. This technology is adaptable to detect lymph node metastasis in vivo as a preclinical model of surgical navigation.
Currently available methods for detection of tumors in vivo such as computed tomography and magnetic resonance imaging are not specific for tumors. Here we describe a new approach for visualizing tumors whose fluorescence can be detected using telomerase-specific replication-competent adenovirus expressing green fluorescent protein (GFP) (OBP-401). OBP-401 contains the replication cassette, in which the human telomerase reverse transcriptase (hTERT) promoter drives expression of E1 genes, and the GFP gene for monitoring viral replication. When OBP-401 was intratumorally injected into HT29 tumors orthotopically implanted into the rectum in BALB/c nu/nu mice, para-aortic lymph node metastasis could be visualized at laparotomy under a three-chip color cooled charged-coupled device camera. Our results indicate that OBP-401 causes viral spread into the regional lymphatic area and selectively replicates in neoplastic lesions, resulting in GFP expression in metastatic lymph nodes. This technology is adaptable to detect lymph node metastasis in vivo as a preclinical model of surgical navigation.
Medical imaging techniques have become an essential aspect of cancer diagnosis, detection, and treatment monitoring. Advances and improvements in the major imaging modalities such as computed tomography, magnetic resonance imaging and ultrasound techniques have increased the sensitivity of visualizing tumors and their metastases in the body 1, 2 . A limiting factor of these techniques is, however, the inability to specifically identify malignant tissues. Positron emission tomography with the glucose analog 18 F-2-deoxy-D-glucose is the first molecular imaging technique that has been widely applied for cancer imaging in clinical settings 3 . Although 18 F-2-deoxy-D-glucosepositron emission tomography has high detection sensitivity, it has some limitations such as the difficulty in distinguishing between proliferating tumor cells and inflammation and the inability in using it for real-time detection of tumor tissues. A relatively inexpensive, robust and straightforward way of defining the location and area of tumors in vivo would greatly aid the treatment of human cancer, especially for surgical procedures. In particular, if tumors too small for direct visual detection and therefore not detectable by direct inspection could be imaged in situ, surgeons could excise such tumors precisely with appropriate surgical margins.
Sentinel lymph node (SLN) mapping is a minimally invasive procedure and widely used in the management of patients with cutaneous melanoma or breast cancer without clinical evidence of nodal metastases 4, 5 . The technique assumes that early lymphatic metastases, if present, are always found first within the SLN, the first tumor-draining lymph node. A SLN free of tumor cells would therefore predict the absence of metastatic disease in the rest of the tumor-draining lymph node basin, which indicates that intensive lymphadenectomy is unlikely to benefit those patients. Several studies have validated this assumption; the sensitivity of intraoperative frozen-section analysis for detection of nodal metastases, however, is relatively low, and high false-negative rates have been reported [6] [7] [8] [9] . In addition, thicker primary and larger SLN tumor size has been shown to be predictive of non-SLN metastasis, presumably because of the altered lymphatic drainage routes. These findings raise doubt about the applicability of this technique in widespread surgical practice; therefore, several different approaches have been taken to directly label tumor cells to visualize and track them in vivo.
The GFP, which was originally identified from the jellyfish Aequorea victoria, is an attractive molecular marker for imaging in live tissues because of the relatively noninvasive nature of fluorescence [10] [11] [12] [13] [14] [15] . We previously demonstrated a real-time fluorescence optical imaging of pleural dissemination of human non-small-cell lung cancer cells in an orthotopic mouse model using tumor-specific replication-competent adenovirus (OBP-301, Telomelysin) 16, 17 in combination with replication-deficient adenovirus expressing GFP (Ad-GFP) 18 . In the present study we additionally modified OBP-301 to contain the GFP gene driven by the cytomegalovirus (CMV) promoter for monitoring viral replication. The resultant adenovirus, termed OBP-401, efficiently labeled tumor cells with green fluorescence in vitro and in vivo. The results showed that injection of OBP-401 into primary tumors allows its lymphatic spread, which in turn induces viral replication in metastatic lymph nodes, thereby leading to the direct imaging of micrometastases. This technology is adaptable to detect lymph node metastasis in vivo as a preclinical model of surgical navigation.
RESULTS
hTERT levels in human cell lines and lymph node metastases To confirm the specificity of telomerase activity in human cancer cells, we measured expression of hTERT mRNA in a panel of human tumor and normal cell lines using a real-time RT-PCR method. Although the expression varied widely, all tumor cell lines derived from different organs expressed detectable levels of hTERT mRNA, whereas human fibroblast cells lines such as the normal human lung fibroblast (NHLF) and normal human lung diploid fibroblast (WI38), human vascular endothelial cells, and normal human renal epithelial cells were negative for hTERT expression (Fig. 1a) . We also examined samples of 30 primary tumors and 39 lymph node metastases obtained from gastric cancer patients for hTERT protein expression by immunohistochemistry (Supplementary Table 1 online). As shown in Fig. 1b , hTERT staining was clearly observed in metastatic foci of gastric cancers, although most of the lymphocytes present in lymph nodes were negative for hTERT except in some germinal centers. These results suggest that the hTERT promoter element can be used to target human cancer.
Selective visualization of human cancer cells in vitro
We constructed the tumor-specific replication-competent adenovirus OBP-401, which expresses GFP by inserting the GFP gene under the control of the CMV promoter at the deleted E3 region of the telomerase-specific replication-selective type 5 adenovirus OBP-301 (refs. 16,17) (Fig. 1c) . To evaluate the replication ability of OBP-401 in different cell lines, we measured the relative amounts of E1A DNA by quantitative real-time PCR analysis. Human cancer cells (H1299 and SW620) and normal cells (NHLFs) were infected with OBP-401 at a multiplicity of infection (MOI) of 10 for 2 h, followed by incubation in the medium. Cells were harvested at various times during the 3 d after infection, and the virus yield was determined by quantitative real-time PCR assay targeting for the viral E1A sequence. The ratios were normalized by dividing the value of cells obtained 2 h after viral infection. In SW620 and H1299 cells, OBP-401 replicated 6-7 logs by 3 d after infection; OBP-401 replication, however, was attenuated up to 3 logs in normal NHLFs (Fig. 1d) . These findings indicate that OBP-401 viral recovery was reduced by 3-4 logs in normal cells as compared with cancer cells. We also found an apparent correlation between viral yields at 24 h after OBP-401 infection and hTERT mRNA expression in human cancer cell lines (Fig. 1e) .
To determine whether OBP-401 replication is associated with selective GFP expression, cells were analyzed and photographed by fluorescent microscope after OBP-401 infection. As shown in Fig. 2a , H1299 human non-small-cell lung cancer cells expressed bright GFP fluorescence as early as 12 h after OBP-401 infection at an MOI of 10. The fluorescence intensity gradually increased in a dose-dependent fashion until B72 h after infection, followed by rapid cell death due to the cytopathic effect of OBP-401, as shown by floating, highly light-refractile cells under phase-contrast photomicrographs. In SW620 and HT29 human colorectal cancer cells we detected GFP expression 24 h after infection with 10 MOI of OBP-401, and cells showed the cytopathic effect at 72 h after infection (Fig. 2b,c) . In contrast, normal NHLF cells were negative for GFP expression after OBP-401 infection (Fig. 2d) . These results indicate that OBP-401 can replicate exclusively in human cancer cells, leading to tumor cell-specific GFP fluorescence expression in vitro. We detected replicating virus particles in human cancer cells by transmission electron microscopy ( Fig. 2e) . The cytopathic effect of OBP-401 was also assessed by the cell viability assay using the tetrazolium salt XTT. In both SW620 and HT29 cells, OBP-401 infection induced rapid cell death in a dose-dependent manner ( Supplementary Fig. 1a online). In nu/nu mice carrying subcutaneous SW620 human colorectal tumor xenografts, intratumoral injection of OBP-401 resulted in a significant inhibition of tumor growth as compared with mocktreated tumors ( Supplementary Fig. 1b online) .
Selective visualization of subcutaneous tumors in vivo
It is reported that the hTERT promoter could be used to induce transgene expression in syngenic tumors in mice 19 . We first confirmed that OBP-401 could replicate and express GFP fluorescence in Colon-26 cells in vitro as well as in vivo ( Supplementary Fig. 2a ,b online). In contrast, OBP-401 replication was attenuated in mouse splenocytes ( Supplementary Fig. 2a online) . These results suggest that the hTERT promoter can efficiently use the mouse transcriptional machinery and, therefore, the selectivity of OBP-401 can be examined in human tumor xenografts in mice.
To assess the specificity of the GFP-based fluorescent optical detection of tumors in vivo, we examined the kinetics of GFP transgene expression in subcutaneous SW620 and HT29 tumors after intratumoral injection of 1 Â 10 7 PFU per 100 ml of OBP-401 with the charged-coupled device (CCD) noninvasive imaging system. Whole-body images of mice showed that intratumoral GFP fluorescence signals were detectable within 24 h after local delivery of viruses (Fig. 3a) . The fluorescence intensity reached maximum levels within 4 d after injection and was maintained for at least 7 d. When SW620 tumors were removed 14 d after intratumoral injection of OBP-401, the high GFP transgene expression was visible on the surface of tumors as well as across serially sliced sections (Fig. 3b) . No GFP fluorescence was detected when non-tumor-bearing mice were subcutaneously injected with 1 Â 10 7 PFU per 100 ml of OBP-401 (Fig. 3c) , suggesting confinement of GFP expression to the tumor. 
Orthotopic mouse model of human rectal cancer with metastasis
The development of the orthotopic implantation technique for human rectal cancer has been described 20 . Our preliminary experiments revealed that, when 5 Â 10 6 HT29 human colorectal cancer cells suspended in Matrigel are inoculated into the rectum submucosa of athymic nu/nu mice, rectal tumors appeared within 7 d after tumor injection (Fig. 4a,b) . Histopathological examination of the excised primary tumor showed a submucosal tumor formation composed of implanted HT29 cells with a solid architecture and invasion into the muscularis propria and submucosa (Fig. 4c) . Examination under high magnification showed tumor cell-filled lymphatic vessels in the muscularis propria layer (Fig. 4c) . As expected, we detected the green fluorescence expression from 24 h after intratumoral administration of OBP-401 in the primary rectal tumors, with maximum signal occurring 2-4 d after injection, whereas tumors not injected with OBP-401 were completely GFP negative (Fig. 4d) .
Selective visualization of lymph node metastasis
In our preliminary experiments, we confirmed that most mice with rectal tumors subsequently developed lymph node metastasis around the abdominal aorta from the lower margin of the renal vein to the aortic bifurcation, which were microscopically detectable B4 weeks after tumor inoculation. Five days after injection of 1 Â 10 8 PFU of OBP-401 into the implanted rectal tumors, we explored the abdominal cavity at laparotomy. Analyses of two representative mice are shown in Figure 4 . Three lymph nodes (LN1, LN2 and LN3) were macroscopically identified adjacent to the aorta (Fig. 4e,f) ; the optical CCD imaging of the abdominal cavity, however, demonstrated that only one lymph node (LN3) could be detected as light-emitting spots with GFP fluorescence (Fig. 4f) . In the other mouse, three of four lymph nodes could be imaged as GFP signals (Fig. 4h) . We detected no GFP fluorescence in abdominal lymph nodes after injection of 1 Â 10 7 PFU of OBP-401 into the rectal tumors (data not shown). Histopathological analysis confirmed the presence of metastatic adenocarcinoma cells in the lymph nodes with fluorescence emission, whereas GFP-negative lymph nodes contained no tumor cells (Fig. 4g,i) . In addition, immunohistochemical analysis for GFP protein demonstrated that the reddish brown GFP-immunoreactive cells corresponded to the microscopic metastatic nodules in the lymph nodes but were not detected in the nonmetastatic lymphocyte area (Supplementary Fig. 3 online) .
We verified the GFP-based fluorescence detection with OBP-401 and histological correlation of lymph node metastasis in a series of in vivo experiments. Representative examples of the data are summarized in Table 1 . Among the 7 tumor-bearing mice, 6 mice (85.7%) developed histologically confirmed lymph node metastasis. Of 28 lymph nodes excised from 7 mice, histopathological analysis demonstrated that 13 nodes (46.4%) contained micrometastatic nodules. The optical CCD imaging detected 12 lymph nodes labeled in spots with GFP fluorescence in 13 metastatic nodes (sensitivity of 92.3%). Among 15 metastasis-free lymph nodes, 2 nodes were GFP positive (specificity of 86.7%). Our results indicate that intratumoral injection of OBP-401 causes viral spread into the regional lymphatic area and selective replication in cancer cells in metastatic lymph nodes, which in turn could be imaged with GFP fluorescence. Moreover, the finding that OBP-401 did not express GFP fluorescence in a mouse para-aortic lymphadenitis model induced by inoculating complete Freund adjuvant into the rectum submucosa of immunocompetent BALB/c mice suggests that this strategy could distinguish cancer metastasis from inflammatory lymphadenopathy ( Supplementary Fig. 4 online).
DISCUSSION
Lymph node status provides important information for both the diagnosis and treatment of human cancer 21, 22 . Lymphatic invasion is one of the major routes for cancer cell dissemination, and adequate resection of locoregional lymph nodes is required for curative treatment in patients with advanced malignancies. The risk of having lymph node metastasis can be partially predicted by clinical data such as tumor stage, serum tumor marker concentration and medical images; there are, however, no noninvasive approaches to accurately predict the presence of lymph node metastasis, in particular, microscopic metastasis. The specific aim of the present study was to determine the suitability of telomerase-specific amplification of the GFP gene for real-time imaging tumor tissues and, if so, detect nodal metastasis in vivo before the traditional, cumbersome procedures of histopathological examination. GFP-based fluorescence imaging can allow real-time detection of target cells without time-consuming steps such as fixation and tissue processing [13] [14] [15] . Indeed, Yang et al. have shown that GFP-expressing tumors growing and metastasizing in intact animals could be viewed externally with a whole-body optical imaging system 13 . Moreover, the GFP gene could be delivered to metastatic tumor cells in vivo by viral vectors 14 .
To distinguish normal from neoplastic tumor tissues, selective labeling of tumor cells is required. OBP-401 produced a viral yield of 6-7 logs in human cancer cells within 3 d of infection, which was 3-4 logs higher than that in normal cells, suggesting the reliable tumor selectivity of OBP-401. Although the reason why OBP-401 replicated slightly in NHLFs despite the lack of hTERT mRNA expression is unclear, the fact that NHLFs could be maintained in the culture up to passages 10-20 indicates that NHLFs might have a weak telomerase activity that is undetectable by standard PCR assay. However, the attenuated replication property of OBP-401 in normal cells seems not to interfere with the visualization of tumor cells in vivo. In fact, we detected no GFP expression in adjacent normal tissues in subcutaneous human cancer xenografts after intratumoral injection of OBP-401, although the cross-sections of the tumor were entirely imaged with GFP fluorescence. Thus, OBP-401 provides possible probing of tumor cells in vivo.
Experiments using a three-CCD optical imaging system demonstrated that metastatic lymph nodes could be detected at laparotomy in mice 5 d after OBP-401 injection into implanted primary human rectal tumors. Notably, metastatic lymph nodes were imaged in spots with GFP fluorescence, which coincided with histologically confirmed micrometastasis. This experiment mimics the clinical scenario in which patients with gastrointestinal malignancies with lymph node metastasis undergo surgery, and the data suggest that the surgeon can identify metastatic lymph nodes by illuminating the abdominal cavity with a xenon lamp. The sensitivity and specificity of this imaging strategy are 92.3% and 86.7%, respectively; these results are sufficiently reliable to support the concept of this approach. In our phase I trial of a replication-deficient adenovirus vector expressing the wild-type p53 gene (AdCMV-p53, ADVEXIN) , DNA-PCR analysis targeting the viral genome indicated that the virus was present in tumor tissue as well as proximal lymph nodes, suggesting regional spread of the vector via the lymphatic vessels 23 . Therefore, OBP-401 is likely to be accessible to the regional lymph nodes via intratumoral administration in humans. Currently, analysis of lymph nodes with H&E staining and microscopic examination usually involves review of only one or two tissue sections, and small foci of tumor cells can be missed. For intraoperative frozen-section analysis of SLNs, this underestimation is even more pronounced as a result of poor tissue architecture. In the treatment of breast cancer and melanoma, in which SLN biopsy is commonly used, the sensitivity of intraoperative frozen-section analysis ranges from 38% to 74% (refs. 6-9). In our experiments, additional serial sectioning was needed in 4 of 12 (33.3%) lymph nodes with GFP fluorescence to detect micrometastasis. This finding suggests that this GFP-based approach has higher sensitivity for detecting occult lymph node metastasis as compared with standard histopathological examination. Thus, the two GFP-positive nodes, in which tumor cells were not detected histologically, could have contained microscopic metastasis that would have been identified by further sectioning. Other possible explanations of false-positive detection include either that GFP protein itself was produced in the primary tumor spread into regional lymph nodes or that high doses of OBP-401 entered nodes and incidentally replicated in normal lymphocytes in that they have low telomerase activity 24 .
Although the molecular imaging strategy using OBP-401 is considered promising, some limitations of the system exist, the main one being the relatively short wavelength of excitation light of GFP. In contrast to luciferase, which is also commonly used for molecular imaging 25 , if objects are located in the deep layer or covered with thick adjacent tissues, the excitation light for GFP may not be able to reach them. For example, when tumor foci were exposed to the surface of nodes opposite the illuminated field, GFP fluorescence could not be detected, thereby leading to false-negative detection. The extension of exposure time to the illumination allows increasing the fluorescence intensity; the excitation light, however, cannot penetrate deeper. To raise the imaging sensitivity, one possible approach is to make the specimen thinner, for example, by pressing the excised lymph nodes flat; the architecture of the nodes, however, may be destroyed. Alternatively, it might be useful to develop a hand-held probe, in which the outlet of the excitation beam light and the sensor of GFP fluorescence are combined. During surgery, metastatic lymph nodes could be positively identified with GFP fluorescence guided by this probe like a gamma probe for SLN biopsy. At least, a hand-held flashlight to excite GFP fluorescence has been reported 26 .
Administration of OBP-401 can provide an additional advantage in cancer therapy. OBP-401, similar to OBP-301, is an oncolytic virus and selectively kills human tumor cells by viral replication; the process of cell death by OBP-401, however, is relatively slow in comparison with apoptosis-inducing chemotherapeutic drugs, because the virus needs time for replication. Therefore, tumor cells infected with OBP-401 express GFP fluorescence and then lose viability, allowing the timing of detection. We could speculate that OBP-401 would spread into the regional lymph nodes after intratumoral injection, express GFP signals in tumor cells by virus replication and finally kill tumor cells even if the surgeon failed to remove all nodes containing micrometastasis. Thus, the oncolytic activity of OBP-401 may function as a backup safety antitumor program.
In conclusion, we have demonstrated that the GFP-expressing telomerase-specific replication-selective adenovirus OBP-401 can be delivered into human tumor cells in regional lymph nodes and replicate with selective GFP fluorescence after injection into the primary tumor in an orthotopic rectal tumor model. The feasibility of original OBP-301 (Telomelysin) for human cancer therapy will be confirmed in clinical trials in the near future. Because the safety profiles of these two viruses are considered homologous, this molecular imaging strategy using OBP-401 has a potential of being widely available in humans as a navigation system in the surgical treatment of malignancy.
METHODS
Cell culture. The human non-small-cell lung cancer cell lines H1299 and H460, the human gastric cancer cell lines MKN28 and MKN45, the human colorectal cancer cell lines SW620 and HT29, the human esophageal cancer cell lines TE8 and T.Tn, the human prostate cancer cell lines LNCaP and PC-3, the human tongue squamous carcinoma cell lines HSC-3, HSC-4, SCC-4 and SCC-9, the human cervical adenocarcinoma cell line HeLa, the human hepatocellular carcinoma cell line HepG2, the human pancreatic cancer cell line Panc-1, the human mammary gland adenocarcinoma cell line MCF-7, the human osteosarcoma cell line U-2OS (ATCC), the NHLF cell line, the normal human renal epithelial cell line HRE, the human umbilical vascular endothelial cell line HUVEC (TaKaRa Biomedicals) and the normal human lung diploid fibroblast cell line WI38 (HSRRB) were cultured according to the vendor's specifications.
OBP-401. OBP-401 is a telomerase-specific replication-competent adenovirus variant in which the hTERT promoter element drives the expression of E1A and E1B genes linked with an internal ribosome entry site, with the GFP gene inserted under the CMV promoter into the E3 region for monitoring viral replication 27, 28 . The virus was purified by ultracentrifugation in cesium chloride step gradients, their titers were determined by a plaque-forming assay using 293 cells and they were stored at -80 1C.
Quantitative real-time PCR analysis. Total RNA from the cultured cells was obtained using the RNeasy Mini Kit (QIAGEN). The hTERT mRNA copy number was determined by real-time quantitative RT-PCR using a LightCycler instrument and a LightCycler DNA TeloTAGGG Kit (Roche Molecular Biochemicals). DNA was extracted with the QIAamp DNA Mini Kit (QIA-GEN), and quantitative real-time PCR assay for the E1A gene was also performed. The sequences of specific primers used for E1A were, sense: 5¢-CCTGTGTCTAGAGAATGCAA-3¢; antisense: 5¢-ACAGCTCAAGTCCAAAG GTT-3¢. PCR amplification began with a 600-s denaturation step at 95 1C and then 40 cycles of denaturation at 95 1C for 10 s, annealing at 58 1C for 15 s and extension at 72 1C for 8 s. Data analysis was performed using LightCycler Software (Roche Molecular Biochemicals). The ratios normalized by dividing the value of untreated cells were presented for each sample.
Fluorescence microscopy. Human cancer cell lines (H1299, SW620 and HT29) and normal cells (NHLFs) were infected with either 1 or 10 MOI of OBP-401 for 2 h in vitro. Expression of the GFP gene was assessed and photographed (magnification: Â200) using an Eclipse TS-100 fluorescent microscope (Nikon).
Electron microscopy. Human prostate cancer cell line LNCaP was infected with 10 MOI of OBP-401. Thin sections were cut on coated copper grids and stained with uranyl acetate. The samples were examined and photographed with a Hitachi H-7100 transmission electron microscope.
Immunohistochemistry. Immunohistochemical staining was performed using a Histofine SAB PO kit (Nichirei) according to the manufacturer's instructions. Paired tissues of primary tumors and lymph node metastases were obtained from gastric cancer patients who underwent surgery at Okayama University Hospital. Informed consent was obtained from each individual as approved by the Ethics Review Committee for Clinical Investigation of our institution. Formalin-fixed, paraffin-embedded tissue sections were mounted on silanized slides and deparaffinized. After blocking of nonspecific reactivity with rabbit or goat serum for 10 min at 25 1C, sections were incubated overnight at 4 1C with the monoclonal antibody to hTERT (Kyowa Medex). After rinsing, the slides were incubated with biotinylated rabbit antibody to mouse, and then with avidin-biotin-peroxidase complex. Peroxidase activity was determined using DAB-H 2 O 2 solution (Histofine DAB substrate kit; Nichirei). The slides were counterstained with methyl green and Mayer's hematoxylin.
Animal experiments. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of our institution. We produced SW620 and HT29 xenografts on the back in 5-week-old female BALB/c nu/nu mice by subcutaneous injection of 5 Â 10 6 SW620 or HT29 cells in 100 ml of HBSS using a 27-gauge needle. When tumors grew to B6-7 mm in diameter, both tumors were intratumorally injected with OBP-401 (1 Â 10 7 PFU/100 ml). Mice were anesthetized by intraperitoneal injection of pentobarbital (50 mg/kg) and examined for GFP expression. Six mice were used for each tumor cell line. To generate an orthotopic rectal cancer model, female BALB/c nu/nu mice were anesthetized and then placed in a supine position. The anorectal wall was cut at a length of 7 mm to prevent colonic obstruction resulting from rectal tumor progression. We injected cell suspension of HT29 cells at a density of 5 Â 10 6 cells in 100 ml of Matrigel basement membrane matrix (Becton Dickinson Labware) slowly into the submucosal layer of the rectum through a 27-gauge needle (Fig. 4a) . Four weeks later we injected 1 Â 10 8 PFU/100 ml of OBP-401 directly into the rectal tumors. Mice were killed, and their abdominal spaces were examined at laparotomy 5 d after virus injection.
Cooled CCD imaging. In vivo GFP fluorescence imaging was acquired by illuminating the animal with a xenon 150-W lamp. The re-emitted fluorescence was collected through a long-pass filter on a Hamamatsu C5810 3-chip color CCD camera (Hamamatsu Photonics Systems). High-resolution images were acquired using an EPSON PC. Images were processed for contrast and brightness with the use of Adobe Photoshop 4.0.1J software (Adobe).
Note: Supplementary information is available on the Nature Medicine website.
